Zobrazeno 1 - 10
of 200
pro vyhledávání: '"VC. Tjan-Heijnen"'
Autor:
WK de Roos, Frans L. G. Erdkamp, H de Graaf, IE van Hellemond, M. de Boer, M. van der Sangen, Carolien H. Smorenburg, Aafke H. Honkoop, F.W.P.J. van den Berkmortel, Carine Seynaeve, VC Tjan-Heijnen, Astrid C P Swinkels, Pgm Peer, A.L.T. Imholz, Judith R. Kroep, Sabine C. Linn
Publikováno v:
Cancer Research. 79:P4-14
Background: The phase III DATA study (NCT00301457) investigates the efficacy of 6 versus 3 years of adjuvant anastrozole after an initial 2-3 year treatment with tamoxifen in postmenopausal women with breast cancer. A reduced bone mineral density (BM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4f54217b9be8bb4c1e26f3c455d9008
https://doi.org/10.1158/1538-7445.sabcs18-p4-14-11
https://doi.org/10.1158/1538-7445.sabcs18-p4-14-11
Autor:
Sandra M. E. Geurts, M van Kleef, VC Tjan-Heijnen, M. de Boer, RS Schmitz, Khava I.E. Ibragimova
Publikováno v:
Cancer Research. 79:P1-08
In advanced breast cancer (ABC), a growing number of treatment options have become available the past 10 years, increasing overall survival. Healthcare use near the end of life has increased, although specific data for ABC are limited. This study des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c00f654eb2e662b58ce0e4d9064f37c3
https://doi.org/10.1158/1538-7445.sabcs18-p1-08-20
https://doi.org/10.1158/1538-7445.sabcs18-p1-08-20
Autor:
Stefan Sleijfer, Neeltje Steeghs, Jwm Martens, Emile E. Voest, J. van Riet, Martijn P. Lolkema, Saskia M Wilting, Tessa G Steenbruggen, Haiko J. Bloemendal, Mariette Labots, VC Tjan-Heijnen, JM van Riel, A. Jager, Lindsay Angus, H.J.G. van de Werken, Edwin Cuppen, Marcel Smid
Publikováno v:
Cancer Research. 79:GS1-07
Background: In depth sequencing of primary breast cancer (BC) has identified a heterogeneous repertoire of disease drivers, evidence of clonal evolution and underlying mutational processes. As cancer evolves over time and under treatment pressure, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0befd148230f72bb6b0bbda61af5b3f6
https://doi.org/10.1158/1538-7445.sabcs18-gs1-07
https://doi.org/10.1158/1538-7445.sabcs18-gs1-07
Autor:
Joost R. C. Lameijer, VC Tjan-Heijnen, Frits H. Jansen, Wikke Setz-Pels, Mireille J. M. Broeders, Adri C. Voogd, Ruud M. Pijnappel, L.J. Strobbe, Lucien E. M. Duijm
Publikováno v:
European Journal of Radiology, 136:109517. Elsevier Ireland Ltd
European Journal of Radiology, 136
European Journal of Radiology, 136
Objectives: To determine the extent and characteristics of delay in breast cancer diagnosis in women recalled at screening mammography.Methods: We included a consecutive series of 817,656 screens of women who received biennial screening mammography i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abe5f4b383f9d83509701876b1f60ffe
https://cris.maastrichtuniversity.nl/en/publications/670ea544-77fe-4d2f-ba9d-dc43f53c687c
https://cris.maastrichtuniversity.nl/en/publications/670ea544-77fe-4d2f-ba9d-dc43f53c687c
Autor:
Marin Strijker, S. M. E. Geurts, L.G.M. van der Geest, I.H.J.T. de Hingh, B. Groot Koerkamp, E. de Jong, K.C. Timmermans, Stefan A W Bouwense, VC Tjan-Heijnen, L. Valkenburg-van Iersel, Cornelius H. C. Dejong, Chantal V. Hoge, J. de Vos-Geelen, Nadia Haj Mohammad, V. E. de Meijer, Jeroen Buijsen, Geert Kazemier, Lara R. Heij, Marc G. Besselink, H.W.M. van Laarhoven, H. Wilmink
Publikováno v:
European Journal of Surgical Oncology, 47(7), 1742-1749. W.B. Saunders
European Journal of Surgical Oncology, 47(7), 1742-1749. ELSEVIER SCI LTD
European journal of surgical oncology, 47(7), 1742-1749. W.B. Saunders Ltd
European Journal of Surgical Oncology, 47(7), 1742-1749. ELSEVIER SCI LTD
European journal of surgical oncology, 47(7), 1742-1749. W.B. Saunders Ltd
Introduction: Ampullary cancer is rare and as a result epidemiological data are scarce. The aim of this population-based study was to determine the trends in incidence, treatment and overall survival (OS) in patients with ampullary adenocarcinoma in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee5623b27d36a44cb9b5cdb4fd627308
https://pubmed.ncbi.nlm.nih.gov/33712346
https://pubmed.ncbi.nlm.nih.gov/33712346
Autor:
Daniel H.L. Lemmers, VC Tjan-Heijnen, Sandra M. E. Geurts, L. Valkenburg-van Iersel, H. Wilmink, A. Benedetti Cacciaguerra, M.G. Besselink, J. de Vos, E. de Jong, M. Abu Hilal
Publikováno v:
HPB. 23:S974-S975
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e45ff0d9986d02a3e928d6f143f6e8c6
https://doi.org/10.1016/j.hpb.2021.08.655
https://doi.org/10.1016/j.hpb.2021.08.655
Autor:
Birgit E.P.J. Vriens, J. Heijnen-Mommers, Frans L. G. Erdkamp, M. de Boer, Bram Ramaekers, VC Tjan-Heijnen, Kirsten N. A. Aaldering, N.A.J.B. Peters, A.J. van de Wouw, Manuela A. Joore, J.M.G.H. van Riel, Manon J. Pepels, Tineke J. Smilde, Xavier Pouwels, S. M. E. Geurts, M.W. Dercksen
Publikováno v:
Acta Oncologica, 59(1), 82-89. Routledge/Taylor & Francis Group
Background: Eribulin provided significant overall survival (OS) benefit in heavily pretreated advanced breast cancer patients in the EMBRACE trial. We investigated the use of eribulin in daily clinical practice, the relative effectiveness of eribulin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f5e7c00bf88dc633622b617038066d
Autor:
Marc B. I. Lobbes, VC Tjan-Heijnen, Loes F. S. Kooreman, S. M. E. Geurts, Esther M. Heuts, Lucien E. M. Duijm, Adri C. Voogd, Kristien Keymeulen
Publikováno v:
The British Journal of Surgery
British Journal of Surgery, 106(11), 1488-1494. Wiley
British Journal of Surgery, 106(11), 1488-1494. Wiley
Background Determinants of the use of breast MRI in patients with ductal carcinoma in situ (DCIS) in the Netherlands were studied, and whether using MRI influenced the rates of positive resection margins and mastectomies. Methods All women aged less
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d44ae9621fe585e29a0581f124c88b6c
https://pubmed.ncbi.nlm.nih.gov/31386197
https://pubmed.ncbi.nlm.nih.gov/31386197
Autor:
Sandra M. E. Geurts, A.J. van de Wouw, Xavier Pouwels, J. Heijnen-Mommers, VC Tjan-Heijnen, N.A.J.B. Peters, Manuela A. Joore, Bram Ramaekers, J.M.G.H. van Riel, Kirsten N. A. Aaldering, Manon J. Pepels, Frans L. G. Erdkamp, Tineke J. Smilde, M. de Boer, Birgit E.P.J. Vriens, M.W. Dercksen
Publikováno v:
Acta Oncologica. 60(5):645-645
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48d39781219e34b3bd5d434af7db440b
https://doi.org/10.1080/0284186X.2021.1885873
https://doi.org/10.1080/0284186X.2021.1885873
Autor:
Pgm Peer, VC Tjan-Heijnen, M. van der Sangen, Judith R. Kroep, F.W.P.J. van den Berkmortel, IE van Hellemond, Sabine C. Linn, M. de Boer, Carolien H. Smorenburg, Jos J. E. M. Kitzen, Aafke H. Honkoop, H de Graaf, Carine Seynaeve, WK de Roos, Frans L. G. Erdkamp, Astrid C P Swinkels, A.L.T. Imholz
Publikováno v:
Cancer Research. 77:S1-03
Background. Even in view of the recent findings of the MA.17R trial, the impact of prolonged aromatase inhibitor (AI) therapy after prior tamoxifen in hormone receptor-positive early breast cancer remains insufficiently clear. Methods. In this open-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ca4661b529a7e882204727621a90664
https://doi.org/10.1158/1538-7445.sabcs16-s1-03
https://doi.org/10.1158/1538-7445.sabcs16-s1-03